In SmithKline Beecham Ltd v Remedica Ltd the EU Intellectual Property Office Cancellation Division rejected SmithKline Beecham’s cancellation application based on its earlier EU trademark ELONTRIL against EU trademark CLONOTRIL owned by Remedica.

Want to read more?

Register to access two of our subscriber only articles per month

Subscribe for unlimited access to articles, in-depth analysis and research from the World Trademark Review experts

Already registered? Log in

What our customers are saying

World Trademark Review is simply the first resource I will go to for trademark-related information, whether about the latest trademark law development or case news, top trademark practitioners or interesting trademark events.

Jerry F Xia
Deputy general counsel and chief IP counsel – Asia-Pacific, corporate law department


Subscribe to World Trademark Review to receive access to the full range of trademark intelligence, insight, and case law, as well as our guides, rankings and daily market insight delivered to your inbox.

Why subscribe?

Share this article